Plains GP Holdings LP (PAGP) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite some positive signals like bullish moving averages and stable analyst ratings, the company's financial performance has been significantly weak in the latest quarter, with a sharp decline in revenue, net income, and EPS. Additionally, the lack of strong trading signals and no recent news catalysts make it less compelling to invest immediately.
The technical indicators show mixed signals. The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 68.04, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot point of 23.395, with resistance at 23.836 and support at 22.954.

Bullish moving averages and stable analyst ratings with recent price target increases by firms like Morgan Stanley and Stifel.
Weak financial performance in Q4 2025, with significant declines in revenue (-12.22% YoY), net income (-663.64% YoY), and EPS (-550.00% YoY). No recent news or significant trading trends from insiders or hedge funds.
In Q4 2025, revenue dropped to $10.56 billion (-12.22% YoY), net income plummeted to $62 million (-663.64% YoY), and EPS fell to 0.27 (-550.00% YoY). However, gross margin improved to 6.97 (+14.45% YoY).
Analyst ratings are mixed but leaning positive. Recent upgrades include Stifel raising the price target to $25 (Buy rating) and Morgan Stanley raising it to $24 (Equal Weight). However, BofA downgraded the stock to Underperform with a $19 price target.